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The role of glycogen in the central nervous system is intimately linked with the glycolytic
pathway. Glycogen is synthesized from glucose, the primary substrate for glycolysis,
and degraded to glucose-6-phosphate. The metabolic cost of shunting glucose via
glycogen exceeds that of simple phosphorylation of glucose to glucose-6-phosphate
by hexokinase; thus, there must be a metabolic advantage in utilizing this shunt
pathway. The dogmatic view of glycogen as a storage depot persists, based on initial
descriptions of glycogen supporting neural function in the face of aglycemia. The variable
latency to conduction failure, dependent upon tissue glycogen levels, provided convincing
evidence of the role played by glycogen in supporting neural function. Glycogen is
located predominantly in astrocytes in the central nervous system, thus for glycogen
to benefit neural elements, intercellular metabolic communication must exist in the
form of astrocyte to neuron substrate transfer. Experimental evidence supports a model
where glycogen is metabolized to lactate in astrocytes, with cellular expression of
monocarboxylate transporters and enzymes appropriately located for lactate shuttling
between astrocytes and neural elements, where lactate acts as a substrate for oxidative
metabolism. Biosensor recordings have demonstrated a significant steady concentration
of lactate present on the periphery of both central white matter and peripheral nerve
under unstimulated baseline conditions, indicating continuous cellular efflux of lactate to
the interstitium. The existence of this lactate pool argues we must reexamine the “on
demand” shuttling of lactate between cellular elements, and suggests continuous lactate
efflux surplus to immediate neural requirements.
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INTRODUCTION
In the last 20 years interest in brain energy metabolism, and in
particular specific cellular substrate utilization and trafficking of
metabolites between neural elements and glia has witnessed a
rapid growth, which shows no sign of abating. This is due to
several factors which may be identified as follows: the realiza-
tion that certain neurological conditions e.g., Alzheimer’s dis-
ease, may in part be due to metabolic disturbance in the brain
(Cai et al., 2012), improved or novel technologies revealing pre-
viously unavailable information regarding metabolism (Brown
et al., 2012; Barros et al., 2013), and an increased awareness of
the importance of the role of lactate (Dienel and Hertz, 2001;
Dienel, 2004). It is this final topic that is the subject of this
review article. The dogmatic view of lactate is as a waste product,
the result of incomplete metabolism of glucose, where glucose is
glycolytically converted to pyruvate / lactate but not oxidatively
metabolized (Stryer, 1995). The role of lactate in the periphery
must not be confused with its role in the CNS. In the periph-
ery, and in particular muscle, lactate is the result of incomplete
oxidative metabolism of glucose (Stryer, 1995), and has entered
the common vernacular in relation to sport e.g., lactate threshold
(Messonnier et al., 2013). The lactate accumulation is due to the
bodies’ inability to take in sufficient oxygen during intense exer-
cise to completely metabolize available glucose, with the shortfall
between oxygen uptake and glucose availability being manifest as
an accumulation of lactate. As an aside, it has recently been shown
that the lactate generated in the periphery as a result of maximal
exercise is not a waste product after all, and crosses the blood
brain barrier where it is oxidatively metabolized by the brain
(Dalsgaard, 2006), although glucose is still the main energy sub-
strate. The relationship shows a degree of metabolic co-operation
between the muscles and the brain, whereby the muscle takes
up all available glucose, the only substrate muscle can efficiently
metabolize, for instantaneous energy production, and the brain
extracts lactate from the systemic circulation, which can exceed
5mmol l−1 during maximal exercise (Dalsgaard, 2006). Brain
energy metabolism is more complex than that which occurs in
muscle due to the variety of different cell types in the brain,
each of which has individual requirements dependent upon func-
tion. Given the absolute requirements of glucose and oxygen as
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the main energy support of the brain, and the extremely rapid
(6–8 s) loss of consciousness that occurs when blood supply to
the brain is interrupted for even the shortest period of time
(Rossen et al., 1943), glucose and oxygen are clearly vital com-
modities to the brain. Thus, it is surprising that not all glucose is
oxidatively metabolized in the brain. If such were the case the res-
piratory quotient (RQ; the ratio of oxygen molecules consumed
per glucose molecule metabolized) for the brain would be 6 (as
6 oxygen molecules are required in the metabolism of one glu-
cose molecule, which contains 6 carbon molecules); the RQ for
resting brain is in fact nearer 5.5 indicating a significant propor-
tion of the glucose is not oxidatively metabolized. In addition this
ratio decreases with increased activity, falling to values as low as 3
(Dienel, 2009). This provokes several questions: what is the ben-
efit to the brain of incomplete glucose oxidation? Is there cellular
compartmentalization with regard to glucose metabolism, and if
so how does this change during increased tissue energy demand?
What role does glycogen play in this scheme?
THE RODENT OPTIC NERVE MODEL
In our studies of brain energy metabolism we have chosen the
rodent optic nerve as a model of central white matter (Ransom
et al., 1997). In the adult human brain white matter occupies 50%
of brain volume whereas the equivalent is only about 15% in the
rodent, a ratio that clearly illustrates the high degree of inter-
regional connectivity (Zhang and Sejnowski, 2000; Karbowski,
2003). Thus, any metabolic disturbances within the brain are
likely to affect both gray and white matter areas. The optic nerve
offers the following advantage over other white matter tissue,
such as the corpus callosum and the ventral column of the spinal
cord, in that it is easy to remove without damaging the tissue.
An additional advantage is that the stimulus-evoked response
recorded from the optic nerve is a stereotypical triple peaked
profile that offers a stable baseline against which the compound
action potential (CAP) resulting from experimental interventions
can be compared (Stys et al., 1991), whereas corpus callosum and
spinal cord white matter tracts are far more prone to variability in
stimulus evoked potentials due to the plane in which the section
is cut and degree of injury incurred by the tissue during slicing
(Baltan, 2006; Velumian et al., 2011). The optic nerve comprises
myelinated axons (almost all axons are myelinated in the rodent
adult) (Ransom et al., 1997), oligodendrocytes and astrocytes,
and as such it is a simple model system without the complications
of synapses or neuronal cell bodies. In our experimental set-up
the acutely isolated optic nerve is maintained in an oxygenated
chamber at 37◦C and superfused with bicarbonate buffered artifi-
cial cerebrospinal fluid (aCSF) containing 10mM glucose. Under
these circumstances a stable CAP can be recorded for many
hours (Brown et al., 2003b). In vitro experimental studies have
demonstrated that both glucose and lactate (20mM lactate is the
carbon equivalent of 10mM glucose) can fully support the CAP
for extended periods of time (Brown et al., 2003b). When these
experiments commenced over a decade ago the role of oligo-
dendrocytes was ignored with axons and astrocytes of primary
interest, thus only these cells shall be addressed. That glucose can
support function is to be expected, and given the intimate reg-
ulatory roles that astrocytes play in supporting neural elements,
significantly their role in buffering [K+]o (Hoppe et al., 1991),
we conclude that both astrocytes and axons can take up glucose,
and metabolize it efficiently such as to promote the continued
maintenance of the cell i.e., maintain their trans-membrane ion
gradients. In the absence of sufficient glucose-derived ATP the Na
pump would cease to function and the trans-membrane ion gra-
dients would be lost, leading to a decrease and eventual loss of
the CAP (Leppanen and Stys, 1997; Stys, 1998). Substituting glu-
cose with lactate had no material impact on the CAP suggesting
that lactate can be taken up and utilized by both axons and astro-
cytes for extended periods of time. These experiments do not,
however, cover the role of substrate transfer between axons and
astrocytes. For example supplying the nerve with glucose could
result in astrocytes taking up glucose and converting it to lac-
tate, which is then shuttled to the axons (this is in part what the
astrocyte neuron lactate shuttle hypothesis proposes); in such a
condition although supplying exogenous glucose supported axon
function the axons did not take up glucose directly, but survived
on astrocyte-derived lactate. To circumvent such arguments we
used the compounds D-lactate and cinnemate, which block lac-
tate transport, D-lactate as a competitive inhibitor and cinnemate
as a conventional blocker. Neither compound affected the ability
of glucose to support the CAP (Brown et al., 2003a), thus we feel
we can safely assume that axons and astrocytes can directly take
up glucose. These assumptions are supported by the presence of
the glut-1 glucose transporter on astrocyte membranes (Morgello
et al., 1995). The argument for lactate being used independently
by both axons and astrocytes is that it is unlikely a cellular com-
partment would take up lactate and subsequently release it, given
that the uni-directional transport of lactate and H+ is controlled
by their respective trans-membrane ion gradients (Halestrap and
Price, 1999).
The dogma of cellular compartmentalization of metabolism
is that neural elements are oxidative and astrocytic elements are
glycolytic, thus astrocytes produce lactate, which is consumed by
neurons. There is a considerable body of evidence to support this
simplistic assumption, although much of it derives from tissue
culture studies, which must be viewed with caution, as a very
important aspect, namely the intercommunication between cell
types, is absent in these types of study. There are many studies
showing that astrocytes in culture do release lactate when bathed
in a medium containing glucose (Dringen and Hamprecht, 1992;
Dringen et al., 1995). Similar studies of cultured neurons tend
to show that neurons take up, rather than release lactate (Schurr
et al., 1988, 1997a,b). Indeed lactate fuels both neuronal recov-
ery after hypoxia (Schurr et al., 1997a), and is consumed by
neurons in culture at rest, in the presence of normoglycemic glu-
cose (Bouzier-Sore et al., 2006). In our rodent optic nerve model
we investigated the trafficking of lactate between astrocytes and
axons (neural elements), by investigating the role of glycogen in
supporting axon conduction. It is recognized that in adult mam-
malian brain the glycogen resides primarily in astrocytes (Cataldo
and Broadwell, 1986), a serendipitous location as it allows us to
pinpoint the cellular location of glycogen-derived lactate. Our ini-
tial study localized glycogen to astrocytes, and biochemical assay
revealed significant depots of glycogen in the tissue. The glycogen
content was labile, increasing commensurately with elevations
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in bathing glucose concentration. Under conditions designed to
simulate in vivo aglycemia, when aCSF lacking glucose was super-
fused, the CAP was lost, but only after a significant latency of
20min inmouse (Brown et al., 2003a), and 30min in rat (Wender
et al., 2000). The latencies could be altered by experimentally
manipulating the tissue glycogen content prior to aglycemia, such
that elevated glycogen content led to increased latencies and vice
versa (Brown et al., 2003a). Biochemical assay revealed that at
the onset of aglycemia glycogen content fell and continued to
fall until it reached its nadir, which coincided with the loss of
the CAP (Brown et al., 2003a) (Wender et al., 2000). These
results showed that tissue glycogen was metabolized and sup-
ported axon conduction in the absence of exogenously applied
glucose, but that once the glycogen was exhausted the CAP failed.
The nature of the support afforded by glycogen was investigated,
based on assumptions drawn from previously published data,
namely that astrocytes produce lactate and neural elements con-
sume lactate. For this to be the case several conditions must be
met, which can be tested experimentally. First, the astrocytes and
axons must express the means to transport lactate i.e., mono-
carboxylate transporters (MCTs). There are four isoforms of this
transporter (Halestrap, 2012), but we focused on the two isoforms
most likely to be involved, MCT1, which is expressed in tissue
that releases lactate, and MCT2 that is expressed on tissue that
takes up lactate. Immunohistochemical data using specific anti-
bodies that recognize MCT1 and MCT2 in combination with cell
specific markers, namely GFAP for astrocytes and neurofilament
for axons, showed expression patterns supportive of astrocyte
to axon lactate transport, namely axonal MCT2 expression and
astrocytic MCT1 expression. In addition the expression pattern of
the enzyme lactate dehydrogenase demonstrated neuronal expres-
sion of the LDH1 isoform, whereas astrocytes expressed both
LDH1 and LDH5 isoform indicating that both cell types are
capable of inter-converting lactate and pyruvate (Tekkok et al.,
2005).
These experiments convincingly demonstrate glycogen-
derived lactate transport from astrocytes to axons under
conditions of aglycemia. What is of more interest is to determine
the role of glycogen under more physiological conditions, such
as hypoglycaemia, which is a common side effect experienced by
type 1 diabetic patients who use exogenous insulin to manage
their symptoms (Bittar et al., 1996), and under increased tissue
energy demand. Mouse optic nerves superperfused with 10mM
glucose can sustain conduction for many hours. Switching
to 2mM glucose aCSF had no effect on the CAP (Frier and
Fisher, 2007). However, adding cinnemate, which blocks lactate
transport at the MCT causes a decrease in CAP area (Brown
et al., 2003a). In a separate experiment superfusing nerves
with 2mM glucose after previously depleting glycogen with
20min of 0 glucose superfusion caused the CAP to fall (Brown
et al., 2003a). Our conclusion from these experiments is that
2mM glucose is insufficient to fully support the CAP and
that glycogen is metabolized in the astrocyte to lactate, which
is then shuttled to the axon to maintain axon conduction.
Interrupting lactate transport or decreasing glycogen content
results in CAP failure. The mouse optic nerve is able to sustain
firing when stimulated at frequencies of up to 50Hz i.e., the
CAP remains above baseline during sustained stimulation. At
100Hz the CAP area initially increased above baseline due
to the CAP spreading out (Brown et al., 2003a) as a result of
increased extracellular K+ accumulation (Brown et al., 2003a),
followed by a slow decrease below baseline after about 5min.
Addition of isofagomine, an inhibitor of glycogen phosphorylase
(Ransom et al., 1985), or D-lactate, or cinnemate (Brown et al.,
2005), caused a decrease in the CAP, indicative of glycogen
metabolism sustaining the CAP during periods of increased
energy demand. Thus, the increased tissue energy demand
invoked by imposing high frequency stimulus on the nerve,
is not met by ambient glucose concentrations, and glyco-
gen derived lactate provides supplementary energy substrate.
An alternative view has been proposed whereby astrocytes
metabolize glycogen thus maintaining high levels of glucose-
6-phosphate, diverting glucose for neuronal oxidation (Dienel,
2012).
Thus, in the rodent optic nerve any lactate present in the extra-
cellular space is likely to be due to glycogen metabolism under
conditions of increased metabolic need by axons. However, we are
interested in whether glucose contributes to the putative extracel-
lular lactate pool. That astrocytes release lactate, which is taken
up by neural elements has a firm foundation backed up by exper-
imental evidence as described above. However, in the mid 1990’s
the astrocyte neuron lactate shuttle hypothesis (ANLSH) pro-
posed that a significant proportion of glucose delivered to the
brain was shuttled into astrocytes where it was converted to lactate
and subsequently released into the extracellular space and taken
up by neurons (Dienel and Cruz, 2014). However, this scheme
proposed an “on demand” aspect, such that the initiating factor
for the sequence was release of glutamate into synapses, with the
glutamate subsequently taken up by astrocytes, which provoked
glucose uptake. As such the scheme would appear to propose
that under resting conditions there was little lactate trafficking
between astrocytes and neurons, and that this was only initiated
by metabolic need by neurons, and under conditions of increased
energy demand both glucose and glycogen are proposed to be
sources of lactate (Pellerin and Magistretti, 1994). Recent data
has suggested that the brain does not use lactate as an obligate
substrate to the extent that the brain can release lactate into the
systemic circulation, and lactate is only used when present in high
non-physiological concentration (Magistretti et al., 1999).
LACTATE BIOSENSORS
The development of lactate biosensors offered an ideal oppor-
tunity to investigate the dynamics of extracellular lactate. The
rodent optic nerve is an ideal preparation to use as the biosensor
can be placed alongside the nerve, i.e., just outside the meninges,
without damaging the tissue (Yang et al., 2014). It is worthwhile
examining this configuration in detail as illustrated in Figure 1.
In such a configuration the sensor does not record lactate in the
interstitium but rather at the periphery of the nerve. Thus, any
lactate recorded has been released by the nerve and cannot be used
as a substrate i.e., it can be considered surplus to current energy
requirements. Given the superfusion system, there is a constant
flow of aCSF over the sensor, thus the sensor would record any
lactate released by the tissue into the aCSF. What this means is
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that a stable reading of lactate implies there is a constant efflux of
lactate from the nerve, a decreased level means a decreased release
and an increase means an increased release. Compare this to a
static enclosed system, where an acute release of lactate would
be recorded as a continuously elevated level. With this in mind
it is timely to discuss the implications of recent recordings using
lactate biosensors in mouse optic nerve. It is immediately appar-
ent that in nerves perfused with control concentrations of glucose
the lactate concentration was about 500µM (the concentration
may not be an accurate reflection of the interstitial [lactate] due
to continuous superfusion and incomplete contact of the sensor
with the nerve etc.). That such a large concentration is recorded
may be viewed as surprising, but is in agreement with in vivo data
using dialysis techniques that have recorded equivalent concen-
trations (Hu and Wilson, 1997). However, the in vivo situation is
different as the ECS is a stable compartment, and dependent upon
the rate of release or uptake of lactate, may not reflect a vibrant
flux of lactate, but rather a stationary lactate pool. Alternatively,
the conditions present in these experiments in which aCSF lack-
ing lactate superfuses the tissue may exaggerate any true release of
lactate from the tissue due to the extracellular pool lacking lactate.
FIGURE 1 | Recording lactate release from optic nerve. (A) Schematic
illustrating the use of a lactate biosensor (3) to record lactate release from
optic nerve (2). The CAP is recorded via the suction electrodes (1). (B) A
model of possible lactate movements in the continually superfused optic
nerve. The open circles indicate monocarboxylate transporters; Gluc,
glucose; Lac, lactate.
In addition it has recently been shown that extracellular lac-
tate inhibits astrocytic glycolysis (Sotelo-Hitschfeld et al., 2012).
Another intriguing possibility, although we present no evidence
to support it, is that white matter is a lactate producer and gray
matter is a lactate consumer. Such a high level of recorded lac-
tate release warrants comment, and strongly suggests that the
tissue creates and exports lactate to the interstitium irrespective
of metabolic need. This contradicts the ANLSH, where lactate is
exported by astrocytes on demand by neurons (Magistretti et al.,
1999). The compartmentalization of lactate production has not
been elucidated in this system, but it is highly likely that the
glial (astrocytic) component produces most of the lactate, and
thus exports lactate as a continuous process. That the lactate is
released and unutilized is initially surprising, but appears logical
on closer inspection. An axon in an in vivo situation that suddenly
increases its energy demand would be fed by an increase in local-
ized blood flow that is initially via Ca2+ waves in astrocytes, and
as such is not an instantaneous process taking between tens of sec-
onds andminutes. In the latency between this occurring the axons
may be bereft of instantly available glucose if relying in ambient
glucose. However, an additional pool of extracellular lactate may
be an ideal reserve from which axons feed prior to hyperemia.
Introduction of aglycemia to mouse optic nerves led to a rapid
fall in lactate to zero after about 10min. However, this preceded
the fall in the CAP suggesting that lactate is taken up by the axons
during aglycemia, but that once it has been used there is no energy
substrate for the axons to use, and hence CAP failure ensues. On
reperfusion of glucose the lactate rapidly increases, overshoots,
then returns to baseline (Figure 2). The mechanism behind this
overshoot is unknown but may be in part due to the aglycemia-
induced elevated extracellular K+ concentration (Brown et al.,
2001), which is supported by recent data showing K+ stimulated
glycogen degradation in astrocytes mediated by soluble adenyl
FIGURE 2 | Lactate concentration in response to aglycemia. A baseline
period of superfusion with aCSF containing 10mM glucose produced a
stable CAP area and a robust release of lactate from the tissue.
Introduction of aglycaemia caused a rapid fall in lactate to zero, prior to the
fall in the CAP area. On reperfusion of glucose containing aCSF the CAP
rapidly recovered, but the lactate level rapidly overshot before returning to
the baseline levels. The CAP (open squares) is represented on the left
y-axis and the lactate signal (line) is represented on the right y-axes.
Adapted from Figure 4 Yang et al. (2014).
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cyclase (Choi et al., 2012), and astrocyte specific bicarbonate-
sensitive NBCe1-mediated stimulation of glycolysis (Bittner et al.,
2011; Ruminot et al., 2011).
In conclusion, glycogen supports axon conduction in both
peripheral and central axons. The glycogen is located in the
glial compartment in each tissue, and is metabolized to the
transportable conduit lactate, which is shuttled to the axons
to support conduction. Such metabolic cell-to-cell communi-
cation relies on signaling between the cells such that reliable
information is relayed to the glial cells concerning the current
metabolic requirements of the neural elements. Our knowledge
of the mechanism(s) of this communication is incomplete, but
the use of reduced models of brain tissue in combination with
emerging technologies will surely advance our understanding
of the fascinating and complex interaction between neurons
and glia.
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